Back To Search Results

Warty Dyskeratoma

Editor: Sarah J. Ferrer-Bruker Updated: 4/4/2025 4:02:08 AM

Introduction

Warty dyskeratoma is an uncommonly encountered benign proliferative epidermal disorder. However, its name can be misleading, as there is no relationship between this disorder and human papillomavirus (HPV) infection that causes common warts. Histologic features suggest that this benign growth is a follicular neoplasm. Therefore, some suggest naming this entity as a "follicular dyskeratoma."[1] In 1954, Helwig introduced a case of an "isolated dyskeratosis follicularis" due to its similarities with the dyskeratotic papules observed in Darier disease. However, he noted that these isolated lesions were solitary and double or triple the size of the papules found in Darier disease.[2] 

Szymanski first used the term warty dyskeratoma to summarize the salient features of the condition. These features include the common warty clinical morphology, the principal histological finding of dyskeratosis, and "-oma" denoting the tumor-like nature.[3] Ackerman suggested that the term warty dyskeratoma should be restricted to nodular lesions. He proposed that the papular lesions would be better referred to as the papular form of focal acantholytic dyskeratosis.[4]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

The exact etiology of this condition is unknown. Ultraviolet radiation, autoimmunity, viral factors, chemical carcinogens, and smoking have been proposed to play a role in its etiology.[5] In the case of lesions on the oral cavity, oral mucosal trauma (eg, due to biting, ill-fitting denture, or sharp tooth) or tobacco use (smoking or chewing) have been suggested as possible risk factors.[6] For lesions presenting on or near the genital area, human papillomavirus was thought to have a potential role. However, in one of the studies, polymerase chain reaction analysis in 13 lesions of warty dyskeratoma did not reveal any evidence of human papillomavirus DNA.[1] Multiple eruptive lesions of warty dyskeratoma have been described in the case of end-stage renal disease.[7]

Epidemiology

Warty dyskeratomas are typically found in males and middle-aged or older adults aged 40 to 60.[6] No racial predisposition has been identified. 

Pathophysiology

The exact origin of warty dyskeratoma is still unclear. However, this condition is usually described as a follicular adnexal neoplasm, which is supported by the histologic resemblance of the follicular infundibulum and the location usually associated with a pilosebaceous unit (see Image. Warty Dyskeratoma Pathology Architecture).[8] Immunohistochemical analysis of warty dyskeratoma lesions shows cytokeratin (CK) 7 and CK17 expression on the basal layers and CK 1 and 10 on the suprabasal layers. This cytokeratin expression pattern further supports the view that warty dyskeratoma is an adnexal tumor with follicular differentiation.[9] 

Reports of warty dyskeratoma in oral mucosa and subungual areas have been documented; interestingly, both these areas lack hair follicles.[10][11] Mucosal warty dyskeratoma may be associated with ectopic sebaceous glands.[6] Few authors have argued that the cases reported as "oral warty dyskeratoma" are a form of focal acantholytic dyskeratosis, different from the warty dyskeratomas seen on the skin surface.[12]

Some authors believe that the term "follicular dyskeratoma" better describes the lesion as compared to the original name of warty dyskeratoma, as it takes into account the possible follicular derivation and also considers the fact that most of the lesions are not verrucous clinically and a pathogenetic association with human papillomavirus has not been proven yet.[1] The absence of SERCA2 staining by immunohistochemistry, the protein product of ATP2A2, was reported, which suggests that warty dyskeratoma may represent an acquired genetic mutation of ATP2A2.

Histopathology

The lesion has been typically described as originating from a pilosebaceous unit. The distinctive histopathology helps differentiate this lesion from a wide range of similar pathologies. The most common findings include focal acantholysis and dyskeratosis.[1]

Currently, 3 primary architectural patterns have been described. The most common of these patterns is cup-shaped epidermal invagination; the other 2 forms are cystic and nodular. Few cases have shown variable combinations of the 3 patterns.[1] The lesions showing nodular patterns are usually smaller in size; therefore, they have been proposed to represent earlier stages of the lesion. Studies have suggested that the cup-shaped invaginations and cystic forms represent well-developed lesions.[1] The lining of the typical cup-shaped invagination resembles that of the follicular infundibulum.[1] In more than half of the cases, focal continuity to follicular infundibulum is found, while other cases may show the presence of small infundibular cystic structures.

Other histopathological findings include keratotic debris, grains, corps ronds (meaning "round bodies"), and villi formation with suprabasal acantholytic cells and hyalinized or fibrous stroma with intrastromal clefts (see Image. Warty Dyskeratoma Pathology Corps Ronds and Grains).[13] Foci with relatively larger epithelial cells showing abundant eosinophilic cytoplasm and a small dark nucleus may be seen, probably representing an early stage of dyskeratosis. Lymphohistiocytic perivascular infiltration may be noted.

The histopathology of subungual dyskeratoma shows a crater-like area in the nail matrix and nail bed, with intense papillomatosis at the crater's base and deep epithelial digitations in the lining. Areas of acantholysis, dyskeratotic cells, and irregular clefts are seen at the center of the tumor. Numerous multinucleated giant cells in the nail bed have also been reported.[14]

History and Physical

Clinical Features

The lesions are mostly limited to the head and neck area, with few reports of mucosal lesions. Other skin sites reported to be involved are the trunk, extremities, nails, hard palate, and genitalia. Intra-oral lesions are usually found on keratinized mucosa, eg, maxillary and mandibular alveolar ridges and the hard palate. Most of the lesions are found within sun-exposed areas.[15]

The warty dyskeratoma is a skin-colored to grey-pink umbilicated papulonodular lesion with a hyperkeratotic plug in the center and a rolled smooth edge. The size ranges from a few millimeters to a few centimeters. The lesion is usually solitary and asymptomatic.[6] Some patients may complain of pruritis, mild pain, or tenderness. Some authors postulated that itching may be due to eosinophils in histopathology.[16] Lesions on the scalp may have focal alopecia.[17][18]

Multiple lesions of warty dyskeratoma are rare. Several cases of multiple warty dyskeratomas were reported among patients with renal dysfunction.[7][19] Mucosal lesions typically present as white firm papules or nodules with a verrucous surface or central umbilication.[6][20] Warty dyskeratomas, even on the vulvar mucosa, have also been reported.[21] Few cases of subungual dyskeratoma have been reported. These cases present clinically as longitudinal or roundish erythronychia and are sometimes associated with pain.[11]

Evaluation

The clinical diagnosis of warty dyskeratoma may be difficult. Dermoscopy can help in some cases by differentiating the condition from other cutaneous lesions with a similar presentation. The typical dermoscopy features of a warty dyskeratoma consist of central hyperkeratosis with a peripheral collarette of scale.[22][23]

The first reported dermoscopic findings of warty dyskeratoma described a coarse cobblestone pattern. This corresponds with the hyperkeratotic plugs histopathologically.[24] Various descriptive terms such as "milky red doughnut-shaped" areas with "jellyfish-like" or "iris-like" appearance have been used.[25] Central scale crust with polymorphic vessels and pink-white structureless areas may be seen.[26]

Treatment / Management

The definitive treatment of warty dyskeratoma is surgical excision. Curettage or electrodesiccation have also been used. Tazarotene acid gel, laser therapy, and other treatments, eg, 3% 5-floxuridine, 0.1% tretinoin cream, and calamine lotion, have been tried with varying results.[19][27] No risk of malignant transformation or recurrence of warty dyskeratoma is known.(B3)

Differential Diagnosis

The lesion of warty dyskeratoma can be confused with various common cutaneous conditions, both clinically and histopathologically (see Table. Differential Diagnoses Warty Dyskeratoma).

Keratoacanthoma has a similar clinical morphology, with a cup-shaped papulonodule having central depression. However, keratoacanthoma lacks acantholysis or dyskeratosis in histology.[28] Additionally, squamous cell carcinoma can be clinically confused with warty dyskeratoma because of its verruciform appearance and chronic ulceration. However, sarty dyskeratoma does not show any atypia or mitotic activity in a biopsy.

Grover disease, or transient acantholytic dermatosis, is typically a benign, pruritic condition affecting multiple small erythematous papules on the chest or back of middle-aged men. Less commonly, women may also be affected. Histopathologically, focal acantholysis, dyskeratosis, and occasional spongiosis are seen. The primary histological feature of Grover disease is the presence of small foci of acantholysis with dyskeratosis, intraepidermal clefting, and sometimes vesicle formation.

Darier disease, or keratosis follicularis, is an autosomal dominantly inherited condition caused by a mutation in the gene ATP2A2 with multiple greasy, keratotic papules located on the seborrheic areas of the face, upper chest/back, and extremities with guttate leucoderma and cobblestone appearance of the hard palate. Characteristic warty papules on the dorsal hands, similar to acrokeratosis verruciformis, and nail changes (eg, V-shaped nicks and red and white longitudinal bands on the nails) are often present. Histopathologic findings include multiple areas of suprabasal acantholysis with dyskeratosis, corps ronds, and columns of parakeratosis (grains). Acantholytic actinic keratosis may present with acantholysis and dyskeratosis but differs in demonstrating atypical keratinocyte proliferation with cytologic atypia and mitoses.

Warty dyskeratoma is an unusual cause of erythronychia. Glomus tumors of nailbed can have a similar presentation, with erythronychia and pain. Magnetic resonance angiography will help to rule out this vascular tumor. Other uncommon causes of erythronychia, eg, onychopapilloma or melanoma, require histopathological evaluation of the tumor tissue.[29]

Focal acantholytic dyskeratosis was first coined by Ackerman in 1972 in an attempt to describe a distinctive histologic pattern with parakeratotic hyperkeratosis, acantholytic dyskeratosis (at all levels of the epidermis), and focal suprabasal clefts. He classified the lesions by size, number (single or multiple), and duration (persistent and transient), leading to the following 6 distinct classes:

  1. Incidental
  2. Multiple lesions (Darier disease)
  3. Nodular with follicular involvement (warty dyskeratoma)
  4. Papular
  5. Systematized
  6. Transient (Grover disease) [4] 

This finding has been an incidental finding in several skin lesions, including compound and junctional nevi, scars, seborrheic keratosis, basal cell carcinoma, and squamous cell carcinoma.[5]

 Table. Differential Diagnoses Warty Dyskeratoma

Classification Clinical and Histopathological Mimickers Clinical Similarity Clinical Difference Histopathological Similarity Histopathological Differences Dermoscopic Differences
1

Darier disease/Keratosis follicularis

  • Keratotic papules
  • Autosomal dominant inheritance
  • ATP2A2 mutation
  • Multiple lesions
  • Seborrheic distribution 
  • Guttate leucoderma
  • Erythro/leukonychia
  • V-shaped nicking of nail
  • Cobblestoning of the palate
  • Suprabasal acantholysis
  • Dyskeratosis, corps ronds
  • Columns of parakeratosis (grains) 
  • Extensive/multiple areas of acantholysis and dyskeratosis
  • Polygonal, starlike, or roundish-oval-shaped yellowish/brownish areas of various sizes surrounded by a thin whitish halo
2

Grover disease/Transient acantholytic dermatosis

  • Papular lesions
  • Multiple, small erythematous
  • Papules
  • Pruritic
  • Small foci of acantholysis and dyskeratosis
  • Spongiosis, intraepidermal clefting
  • Vesicle formation
  • Central yellowish to brown star-like pattern overlying a pinkish homogeneous structure-less area
3 Squamous cell carcinoma
  • Verrucous
  • Chronic ulceration
  • Bleeding
  • Acantholysis or dyskeratosis in acantholytic squamous cell carcinoma
  • Atypical keratinocyte proliferation with cytologic atypia and mitoses
  • White structures (white circles, white clods, and white structureless areas)
4 Keratoacanthoma
  • Papulonodular lesion with central depression
  • Typically dome-shaped lesion 
  • Hyperkeratosis 
  • Lacks prominent areas of acantholysis and dyskeratosis
  • White structures (white circles, white clods, and white structureless areas)
5 Acantholytic actinic keratoses
  • Keratotic papule in photo exposed area 
  • Mostly in older people with fairer skin types
  • Focal acantholysis dyskeratosis
  • Atypical keratinocyte proliferation with cytologic atypia and mitoses
  • "Strawberry pattern," characterized by a background erythema/red pseudo network consisting of unfocused, large vessels located between the hair follicles, associated with prominent follicular openings surrounded by a white halo
6 Viral wart
  • Skin-coloured to erythematous or brownish verrucous papules 
  • Black dots or hemorrhage
  • Acanthosis and papillomatosis 
  • Typical cytopathic effects 
  • Mosaic pattern and the exophytic keratotic projection pattern (dotted, linear, or hairpin vessels, often surrounded by a whitish halo), often with microhemorrhages

Prognosis

Warty dyskeratoma is a benign condition and has no known risk of malignancy or metastasis.

Complications

Incomplete removal, scarring, or surgical site infection risks are present following the excision of a warty dyskeratoma. Warty dyskeratoma has no risk of systemic involvement.

Consultations

Consultations for warty dyskeratoma may involve multiple specialists to ensure accurate diagnosis and appropriate management. A dermatologist is typically the primary consultant, as they can perform clinical evaluations, dermoscopy, and biopsies to confirm the diagnosis. If histopathologic examination is needed, a dermatopathologist or pathologist analyzes biopsy specimens to distinguish warty dyskeratoma from other skin conditions.

In cases where lesions exhibit atypical features or malignancy is suspected, an oncologist may be consulted for further evaluation. Additionally, if a lesion occurs in the oral cavity or genital region, consultation with an oral medicine specialist or gynecologist may be beneficial. Psychosocial support professionals, including psychologists or social workers, can also provide counseling for patients experiencing anxiety or distress related to their diagnosis. Collaborative consultations ensure comprehensive, patient-centered care.

Deterrence and Patient Education

Deterrence and patient education are essential in managing warty dyskeratoma, as early recognition and appropriate care can prevent unnecessary concerns and interventions. Patients should be educated about the benign nature of the condition and reassured that it is not associated with human papillomavirus (HPV) or malignancy. Healthcare practitioners should emphasize the importance of monitoring skin changes and seeking medical evaluation for any new or evolving lesions. Warty dyskeratoma in unusual locations may cause patients to be anxious and apprehensive; thus, excision and histopathological confirmation are essential for diagnostic confirmation and avoid unnecessary concerns.

Sun protection measures, avoiding skin trauma, and maintaining good overall skin health may help reduce potential risk factors. Clear instructions on wound care, follow-up visits, and signs of recurrence or complications for patients undergoing treatment enhance patient adherence and outcomes. Effective education empowers patients to participate in their care while reducing anxiety and unnecessary medical procedures.

Pearls and Other Issues

Warty dyskeratoma is an uncommonly encountered benign cutaneous lesion that requires histopathological correlation for diagnostic confirmation. 

Enhancing Healthcare Team Outcomes

Enhancing patient-centered care for individuals with warty dyskeratoma requires a coordinated effort among healthcare professionals to ensure accurate diagnosis, effective treatment, and optimal outcomes. Physicians, including primary care clinicians and dermatologists, play a crucial role in identifying lesions, performing necessary biopsies, and determining the best treatment approach. Dermatopathologists and pathologists provide essential diagnostic insights by analyzing biopsy specimens, helping to distinguish warty dyskeratoma from other cutaneous conditions. Advanced practitioners, eg, nurse practitioners and physician assistants, contribute to patient assessments, perform minor procedures, and educate patients on wound care and posttreatment expectations, ensuring continuity of care and improved patient engagement.

Interprofessional communication and collaboration are essential for optimizing patient safety and overall team performance. Oncologists may be involved if a lesion exhibits atypical features, requiring further investigation. Pharmacists ensure the safe and effective use of topical or systemic treatments when needed, providing medication counseling and monitoring for potential adverse effects. Psychosocial support professionals help address emotional concerns related to skin conditions, improving patients’ quality of life. Clinical researchers advance dermatological knowledge by studying diagnostic methods and treatment outcomes. Through shared decision-making and coordinated efforts, healthcare teams can deliver holistic, evidence-based care that enhances both clinical outcomes and patient well-being.

Media


(Click Image to Enlarge)
<p>Warty Dyskeratoma Pathology Architecture</p>

Warty Dyskeratoma Pathology Architecture

Contributed by Rachel Murray, DO


(Click Image to Enlarge)
<p>Warty Dyskeratoma Pathology Corps Ronds and Grains</p>

Warty Dyskeratoma Pathology Corps Ronds and Grains

Contributed by Rachel Murray, DO

References


[1]

Kaddu S, Dong H, Mayer G, Kerl H, Cerroni L. Warty dyskeratoma--"follicular dyskeratoma": analysis of clinicopathologic features of a distinctive follicular adnexal neoplasm. Journal of the American Academy of Dermatology. 2002 Sep:47(3):423-8     [PubMed PMID: 12196754]


[2]

GRAHAM JH, HELWIG EB. Isolated dyskeratosis follicularis. A.M.A. archives of dermatology. 1958 Apr:77(4):377-89     [PubMed PMID: 13519835]


[3]

SZYMANSKI FJ. Warty dyskeratoma; a benign cutaneous tumor resembling Darier's disease microscopically. A.M.A. archives of dermatology. 1957 Apr:75(4):567-72     [PubMed PMID: 13410118]


[4]

Ackerman AB. Focal acantholytic dyskeratosis. Archives of dermatology. 1972 Nov:106(5):702-6     [PubMed PMID: 4635801]


[5]

DiMaio DJ, Cohen PR. Incidental focal acantholytic dyskeratosis. Journal of the American Academy of Dermatology. 1998 Feb:38(2 Pt 1):243-7     [PubMed PMID: 9486681]

Level 2 (mid-level) evidence

[6]

Ghasemi Basir HR, Alirezaei P, Ebrahimi B, Khanali S. Oral warty dyskeratoma: An unusual presentation. Dermatology reports. 2020 Jun 25:12(1):8236. doi: 10.4081/dr.2020.8236. Epub 2020 Jun 25     [PubMed PMID: 32670533]


[7]

Jin MF, Ali NS, Vidal NY. Eruptive warty dyskeratomas on the trunk of a man with end-stage renal disease. International journal of dermatology. 2021 Feb:60(2):e76-e78. doi: 10.1111/ijd.15120. Epub 2020 Aug 9     [PubMed PMID: 33502778]


[8]

Kerr PE, Murphy MJ. Warty (follicular) dyskeratoma on the mons pubis. International journal of women's dermatology. 2017 Sep:3(3):154-156. doi: 10.1016/j.ijwd.2017.07.003. Epub 2017 Jul 26     [PubMed PMID: 28831426]


[9]

Diallo M, Cribier B, Scrivener Y. [Warty dyskeratoma: infundibular histogenesis. Anatomoclinical study of 43 cases]. Annales de dermatologie et de venereologie. 2007 Aug-Sep:134(8-9):633-6     [PubMed PMID: 17925685]

Level 2 (mid-level) evidence

[10]

Peters SM, Roll KS, Philipone EM, Yoon AJ. Oral warty dyskeratoma of the retromolar trigone: An unusual presentation of a rare lesion. JAAD case reports. 2017 Jul:3(4):336-338. doi: 10.1016/j.jdcr.2017.04.014. Epub 2017 Jul 18     [PubMed PMID: 28752125]

Level 3 (low-level) evidence

[11]

Vargas-Laguna E, Imbernón-Moya A, Aguilar-Martínez A, Burgos F. An Unusual Location of Subungual Warty Dyskeratoma: A Case Report and Review of the Literature. Case reports in dermatological medicine. 2017:2017():3613109. doi: 10.1155/2017/3613109. Epub 2017 Feb 23     [PubMed PMID: 28326204]

Level 3 (low-level) evidence

[12]

Allon I, Buchner A. Warty dyskeratoma/focal acantholytic dyskeratosis--an update on a rare oral lesion. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2012 Mar:41(3):261-7. doi: 10.1111/j.1600-0714.2011.01082.x. Epub 2011 Sep 21     [PubMed PMID: 21936875]

Level 3 (low-level) evidence

[13]

Rambhia KD, Makhecha MB. A Case of Warty Dyskeratoma on an Unusual Location. Indian dermatology online journal. 2019 May-Jun:10(3):343-345. doi: 10.4103/idoj.IDOJ_473_18. Epub     [PubMed PMID: 31149593]

Level 3 (low-level) evidence

[14]

Baran R, Perrin C. Focal subungual warty dyskeratoma. Dermatology (Basel, Switzerland). 1997:195(3):278-80     [PubMed PMID: 9407181]

Level 3 (low-level) evidence

[15]

Tanay A, Mehregan AH. Warty dyskeratoma. Dermatologica. 1969:138(3):155-64     [PubMed PMID: 5773508]


[16]

Xie Y, Zhang Q, Wang L. Multiple Warty Dyskeratomas With Severe Pruritus: A Case Report and Literature Review. The American Journal of dermatopathology. 2018 Mar:40(3):e44-e45. doi: 10.1097/DAD.0000000000000984. Epub     [PubMed PMID: 28937437]

Level 3 (low-level) evidence

[17]

Ugras N, Adim SB, Kilicoglu M, Baskan EB. Multiple warty dyskeratomas: case report. Iranian journal of public health. 2014 Aug:43(8):1145-7     [PubMed PMID: 25927045]

Level 3 (low-level) evidence

[18]

Shiraishi K, Sayama K. Multiple Warty Dyskeratomas of the Scalp: A Case Report and Literature Review. Annals of dermatology. 2023 Nov:35(Suppl 2):S345-S346. doi: 10.5021/ad.21.175. Epub     [PubMed PMID: 38061738]

Level 3 (low-level) evidence

[19]

Zhao Q, Zhou H, Geng S. Multiple warty dyskeratoma on the scalp. Anais brasileiros de dermatologia. 2019 Sep-Oct:94(5):630-631. doi: 10.1016/j.abd.2019.09.015. Epub 2019 Sep 30     [PubMed PMID: 31777373]


[20]

Raj AT, Awan KH, Patil S, Morgan P, Warnakulasuriya S. Oral Warty Dyskeratoma-A Systematic Review of the Literature. Diagnostics (Basel, Switzerland). 2022 May 20:12(5):. doi: 10.3390/diagnostics12051273. Epub 2022 May 20     [PubMed PMID: 35626429]

Level 1 (high-level) evidence

[21]

Vaccari S, Rapparini L, Misciali C, Dika E. Vulvar Acantholytic Warty Dyskeratoma. Dermatology practical & conceptual. 2024 Apr 1:14(2):. doi: 10.5826/dpc.1402a124. Epub 2024 Apr 1     [PubMed PMID: 38810041]


[22]

Cortonesi G, Donelli C, Suppa M, Lenoir C, Rubegni P, Cinotti E. Non-Invasive Imaging Techniques (Dermoscopy, Reflectance Confocal Microscopy and Line-Field Confocal Optical Coherence Tomography) for the Diagnosis of Warty Dyskeratoma. Dermatology practical & conceptual. 2024 Jan 1:14(1):. doi: 10.5826/dpc.1401a62. Epub 2024 Jan 1     [PubMed PMID: 38364415]


[23]

Takada T. Warty dyskeratoma: The relationship between its dermoscopic and histopathological findings. Clinical case reports. 2023 Jun:11(6):e7495. doi: 10.1002/ccr3.7495. Epub 2023 Jun 8     [PubMed PMID: 37305894]

Level 3 (low-level) evidence

[24]

Lencastre A, Campos S, Cabete J. Warty dyskeratoma. Journal of the American Academy of Dermatology. 2016 Sep:75(3):e97-e98. doi: 10.1016/j.jaad.2016.02.1157. Epub     [PubMed PMID: 27543244]


[25]

Isaka Y, Matsuda H, Ogita A, Saeki H, Tanaka M, Ansai SI. Case of warty dyskeratoma on the anterior chest: The relationship between its dermoscopic and histopathological findings. The Journal of dermatology. 2018 Jun:45(6):e171-e172. doi: 10.1111/1346-8138.14183. Epub 2017 Dec 21     [PubMed PMID: 29266370]

Level 3 (low-level) evidence

[26]

Di Brizzi EV, Russo T, Piccolo V, Calabrese G, Mascolo M, Alfano R, Argenziano G. Warty dyskeratomas: clinical and dermoscopic features. International journal of dermatology. 2019 Nov:58(11):e229-e231. doi: 10.1111/ijd.14603. Epub 2019 Jul 30     [PubMed PMID: 31361028]


[27]

Abramovits W, Abdelmalek N. Treatment of warty dyskeratoma with tazarotenic acid. Journal of the American Academy of Dermatology. 2002 Feb:46(2 Suppl Case Reports):S4     [PubMed PMID: 11807455]

Level 3 (low-level) evidence

[28]

Lee JH, Uh JA, Kim JH, Lee SK, Kim MS, Lee UH. Warty dyskeratoma on the scalp mimicking keratoacanthoma. Indian journal of pathology & microbiology. 2023 Jul-Sep:66(3):659-660. doi: 10.4103/ijpm.ijpm_230_21. Epub     [PubMed PMID: 37530365]


[29]

Baran R. The red nail--always benign? Actas dermo-sifiliograficas. 2009 Nov:100 Suppl 1():106-13     [PubMed PMID: 20096204]